Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed), eta | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | ImpB/MucB/SamB family protein | 0.0054 | 0.2764 | 0.2764 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0023 | 0.0293 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0293 | 0.5 |
Onchocerca volvulus | 0.006 | 0.3221 | 0.5 | |
Echinococcus granulosus | dna polymerase eta | 0.0054 | 0.2764 | 0.844 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0293 | 0.5 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0023 | 0.0293 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 1 | 1 |
Schistosoma mansoni | DNA polymerase eta | 0.0054 | 0.2764 | 0.844 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0023 | 0.0293 | 0.5 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.006 | 0.3221 | 1 |
Leishmania major | hypothetical protein, conserved | 0.006 | 0.3221 | 1 |
Schistosoma mansoni | hypothetical protein | 0.006 | 0.3221 | 1 |
Echinococcus multilocularis | dna polymerase eta | 0.0054 | 0.2764 | 0.844 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.0293 | 0.5 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.006 | 0.3221 | 0.3016 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.0293 | 0.0293 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0866 | 0.1957 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0023 | 0.0293 | 0.5 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0038 | 0.1473 | 0.403 |
Leishmania major | DNA polymerase eta, putative | 0.0038 | 0.1473 | 0.403 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0054 | 0.2764 | 0.844 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0866 | 0.1957 |
Echinococcus granulosus | tissue type plasminogen activator | 0.006 | 0.3221 | 1 |
Brugia malayi | hypothetical protein | 0.003 | 0.0866 | 0.0866 |
Toxoplasma gondii | kringle domain-containing protein | 0.006 | 0.3221 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.2764 | 0.2545 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.0866 | 0.2319 |
Leishmania major | DNA polymerase eta, putative | 0.0054 | 0.2764 | 0.844 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0038 | 0.1473 | 0.2578 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0054 | 0.2764 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.006 | 0.3221 | 0.3221 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0866 | 0.059 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.006 | 0.3221 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0866 | 0.1957 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.006 | 0.3221 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 1 | 1 |
Brugia malayi | Kringle domain containing protein | 0.006 | 0.3221 | 0.3221 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.3221 | 0.3016 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.006 | 0.3221 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0023 | 0.0293 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.0891 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 2.5119 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.